Panacea Biotec Limited, an Indian biotechnology company, specializes in the research and development, manufacturing, and marketing of pharmaceuticals, vaccines, and biosimilars. The company operates in two segments: Vaccines and Formulations. Its diverse product portfolio includes prescription drugs for various therapeutic areas, such as pain management, diabetes and cardiovascular care, oncology, renal disease management, osteoporosis management, anti-tubercular medications, and gastro-intestinal care. Additionally, Panacea Biotec produces vaccines for diseases like anthrax, dengue, Japanese encephalitis, and more. The company exports its products to more than 30 countries worldwide, including the United States, Germany, the Russian Federation, Sri Lanka, and the Philippines. Notably, Panacea Biotec has entered into collaboration agreements with the Russian Direct Investment Fund, the Coalition for Epidemic Preparedness Innovations, and the Translational Health Science and Technology Institute to develop Covid-19 vaccine candidates, including the Sputnik-V vaccine, and protect against SARS-Cov-2 variants and other Beta coronaviruses. Founded in 1984 and headquartered in New Delhi, India, Panacea Biotec Limited continues to make significant contributions to the healthcare industry.
Navigation section
Panacea Biotec Limited
- 470.00 21.75(4.85%) 472.90 22.50(5.00%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 440.50 436.00 | 470.65 472.90 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 112.35 (04-Jun-2024) 112.70 (04-Jun-2024) | 487.00 (03-Dec-2024) 487.80 (03-Dec-2024) |
- Open
- 440.50 444.00
- Previous Close
- 448.25 450.40
- Volume
- 1.86
- Total Traded value
- 8.68 (₹ Lakhs)
- Upper circuit
- 470.65 225.90
- Lower circuit
- 425.85 150.60
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 411 | 0 |
| Bid Price | Quantity |
|---|---|
| 470.30 | 411.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 411 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹28.79 Cr |
| PE Ratio (TTM): | -205.42 |
| PB Ratio: | 8.38 |
| Industry P/E: | 0.00 |
| Debt to Equity: | - |
| ROE: | -4.08 |
| EPS (TTM): | -2.19 |
| Book Value: | 53.85 |
| Face Value: | 1.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 94.59 Cr | 89.41 Cr | 75.02 Cr | 71.97 Cr | 48.74 Cr |
| Profit | 3.20 Cr | 1.29 Cr | -19.69 Cr | 13.24 Cr | -6.85 Cr |
| Expense | 93.52 Cr | 91.46 Cr | 80.19 Cr | 68.44 Cr | 63.51 Cr |
| Comprehensive income | 3.20 Cr | 1.29 Cr | -21.49 Cr | 13.24 Cr | -6.90 Cr |
| EPS | 0.52 | 0.21 | -3.21 | 2.16 | - |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Panacea Biotec Limited | Sep, 2000 Jan, 1996 | Pharmaceuticals Pharmaceuticals | PANACEABIO PANACEABIO |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Panacea Biotec Limited FAQ's
What is the range of today's stock performance for Panacea Biotec Limited?
Today's stock performance witnessed a fluctuation from a minimum of 440.50 on the NSE (National Stock Exchange) to a maximum of 470.65. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 436.00 to a high of 472.90.
What are the 52-week low and high values for Panacea Biotec Limited?
The stock's performance over the past 52 weeks reveals a low of 112.35 (occurred on 04-Jun-2024) and a high of 487.00 (achieved on 03-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 112.70 (on 04-Jun-2024), and the 52-week high is 487.80 (on 03-Dec-2024).
What was the opening and previous closing prices for Panacea Biotec Limited?
The stock's performance over the past 52 weeks reveals a low of 112.35 (occurred on 04-Jun-2024) and a high of 487.00 (achieved on 03-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 112.70 (on 04-Jun-2024), and the 52-week high is 487.80 (on 03-Dec-2024).
What is the total volume and traded value for Panacea Biotec Limited for the day?
The total volume is 2, and the total traded value is 8.68 (₹ Lakhs).
What are the upper and lower circuit limits for Panacea Biotec Limited?
The upper circuit limit is 470.65, and the lower circuit limit is 425.85.
What is the market cap and PE ratio for Panacea Biotec Limited?
The market cap is ₹28.79 Cr, and the PE ratio (TTM) is 0.00.
What is the PB ratio, industry P/E, and debt to equity ratio for Panacea Biotec Limited?
The PB ratio is 8.73, industry P/E is 0.00 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Panacea Biotec Limited?
ROE is -4.08, EPS is -2.19, book value is 53.85
What are the revenue and profit figures for the latest quarter and previous quarters for Panacea Biotec Limited?
In Sep 2023, Revenue is ₹945900000.00, and Profit is ₹32000000.00. In Jun 2023, Revenue is ₹894100000.00, and Profit is ₹12900000.00.
When was Panacea Biotec Limited listed, and what industry does it belong to?
The company, Panacea Biotec Limited, was listed in Sep 2000 and belongs to the Pharmaceuticals industry. Its NSE symbol is PANACEABIO.
What is the current shareholding pattern of the Panacea Biotec Limited?
As of latest available update, promoters hold 73.59%, the public holds 26.41%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
